Pluri Inc. (PLUR)
NASDAQ: PLUR · Real-Time Price · USD
4.820
+0.270 (5.93%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pluri Employees
As of June 30, 2024, Pluri had 118 total employees, including 106 full-time and 12 part-time employees. The number of employees decreased by 16 or -11.94% compared to the previous year.
Employees
118
Change (1Y)
-16
Growth (1Y)
-11.94%
Revenue / Employee
$5,068
Profits / Employee
-$184,822
Market Cap
26.79M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
DarioHealth | 294 |
IRIDEX | 111 |
NextCure | 82 |
Enlivex Therapeutics | 71 |
Curis | 49 |
Calidi Biotherapeutics | 41 |
LAVA Therapeutics | 37 |
Cognition Therapeutics | 28 |
PLUR News
- 2 days ago - Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease - GlobeNewsWire
- 5 weeks ago - Pluri Inc. to Present at November 21st Virtual Investor Summit Microcap Event - Accesswire
- 5 weeks ago - BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn® Phase 3b Trial Manufacturing - PRNewsWire
- 5 months ago - Pluri's CDMO Selected to Manufacture Kadimastem's Novel Cell Therapy Product Candidates - GlobeNewsWire
- 6 months ago - Pluri: Biotech Play With Several Opportunities Across Different Sectors - Seeking Alpha
- 6 months ago - Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges - GlobeNewsWire
- 7 months ago - U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri's PLX-R18 Acute Radiation Syndrome Contract - GlobeNewsWire
- 7 months ago - Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale - GlobeNewsWire